Shanxi Yanghe Medical Technology Faces Production Halt Over GMP Violation
CompanyDrug

Shanxi Yanghe Medical Technology Faces Production Halt Over GMP Violation

Hansoh Pharmaceutical Secures Dual NMPA Approvals for Oncology Pipeline Expansion
CompanyDrug

Hansoh Pharmaceutical Secures Dual NMPA Approvals for Oncology Pipeline Expansion

Huadong Medicine's DR30206 Approved for Clinical Trials in Gastrointestinal Tumors
CompanyDrug

Huadong Medicine’s DR30206 Approved for Clinical Trials in Gastrointestinal Tumors

Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency
Policy / Regulatory

Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency

Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China
CompanyDeals

Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China

Siemens Set to Acquire Dotmatics for $5.1 Billion to Boost Life Sciences R&D
CompanyDeals

Siemens Set to Acquire Dotmatics for $5.1 Billion to Boost Life Sciences R&D

Lynmou Medical Secures Series A Funding for Endoscope Expansion
CompanyDeals

Lynmou Medical Secures Series A Funding for Endoscope Expansion

Phanes Therapeutics Gains CDE Approval for Peluntamig Phase II Trial in SCLC and NEC
CompanyDrug

Phanes Therapeutics Gains CDE Approval for Peluntamig Phase II Trial in SCLC and NEC

Hengrui Pharmaceuticals Licenses SHR7280 to Merck for Assisted Reproduction
CompanyDeals

Hengrui Pharmaceuticals Licenses SHR7280 to Merck for Assisted Reproduction

Suzhou Ribo Life Science Completes Enrollment for Phase IIa Study of FXI-Targeted siRNA Drug RBD4059
CompanyDrug

Suzhou Ribo Life Science Completes Enrollment for Phase IIa Study of FXI-Targeted siRNA Drug RBD4059

Nanjing King-Friend Bio's Biosimilar Victoza Approved by FDA
CompanyDrug

Nanjing King-Friend Bio’s Biosimilar Victoza Approved by FDA

Bio-Sincerity Pharma-tech Gains NMPA Approval for BIOS-0618 in Obstructive Sleep Apnea
CompanyDrug

Bio-Sincerity Pharma-tech Gains NMPA Approval for BIOS-0618 in Obstructive Sleep Apnea